Fight back against Big Pharma’s greed in Louisiana
About 120 people die every year from hepatitis C in Louisiana, and the struggling state health department’s budget is inadequate to pay for pricey treatments.
Right now, Louisiana is rationing access to treatment because paying for it would mean threatening Medicaid enrollees’ access to care in other areas.
Gilead Sciences priced its medicine unfairly, and now Louisianans like you are footing the bill, all while the disease continues to spread.
But you can help us end that by submitting a comment below to the Louisiana Health Department.